Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine, Weill Cornell Medicine, New York, New York, USA.
Kaiser Permanente Northern California Division of Research, Oakland, California, USA.
Transfusion. 2023 Aug;63(8):1424-1429. doi: 10.1111/trf.17468. Epub 2023 Jun 30.
Anemia in very low birth weight (VLBW) infants is common and frequently managed with red blood cell (RBC) transfusions. We utilized a linked vein-to-vein database to assess the role of blood donors and component factors on measures of RBC transfusion effectiveness in VLBW infants.
We linked blood donor and component manufacturing data with VLBW infants transfused RBCs between January 1, 2013 and December 31, 2016 in the Recipient Epidemiology Donor Evaluation Study-III (REDS III) database. Using multivariable regression, hemoglobin increments and subsequent transfusion events following single-unit RBC transfusion episodes were examined with consideration of donor, component, and recipient factors.
Data on VLBW infants (n = 254) who received one or more single-unit RBC transfusions (n = 567 units) were linked to donor demographic and component manufacturing characteristics for analysis. Reduced post-transfusion hemoglobin increments were associated with RBC units donated by female donors (-0.24 g/dL [95% confidence interval (CI) -0.57, -0.02]; p = .04) and donors <25 years old (-0.57 g/dL [95% CI -1.02, -0.11]; p = .02). For RBC units donated by male donors, reduced donor hemoglobin levels were associated with an increased need for subsequent recipient RBC transfusion (odds ratio 3.0 [95% CI 1.3, 6.7]; p < .01). In contrast, component characteristics, storage duration, and time from irradiation to transfusion were not associated with post-transfusion hemoglobin increments.
Donor sex, age, and hemoglobin levels were associated with measures of RBC transfusion effectiveness in VLBW infants. Mechanistic studies are needed to better understand the role of these potential donor factors on other clinical outcomes in VLBW infants.
极低出生体重(VLBW)婴儿贫血很常见,通常通过红细胞(RBC)输血来治疗。我们利用静脉到静脉的关联数据库,评估了献血者和成分因素对 VLBW 婴儿 RBC 输血效果的影响。
我们将献血者和成分制造数据与 2013 年 1 月 1 日至 2016 年 12 月 31 日期间在 Recipient Epidemiology Donor Evaluation Study-III(REDS III)数据库中接受过 RBC 输血的 VLBW 婴儿进行了关联。考虑到供者、成分和受者因素,使用多变量回归分析了单个 RBC 单位输血后血红蛋白增量和随后的输血事件。
对接受过一个或多个单个 RBC 单位输血(n=567 单位)的 VLBW 婴儿(n=254)的数据进行了关联,以分析供者的人口统计学和成分制造特征。输血后血红蛋白增量减少与女性供者捐献的 RBC 单位有关(-0.24g/dL[95%置信区间(CI)-0.57,-0.02];p=0.04)和年龄<25 岁的供者(-0.57g/dL[95%CI-1.02,-0.11];p=0.02)。对于男性供者捐献的 RBC 单位,供者血红蛋白水平降低与受者随后需要 RBC 输血的风险增加有关(比值比 3.0[95%CI 1.3,6.7];p<0.01)。相反,成分特征、储存时间和从辐照到输血的时间与输血后血红蛋白增量无关。
供者性别、年龄和血红蛋白水平与 VLBW 婴儿的 RBC 输血效果有关。需要进行机制研究,以更好地了解这些潜在供者因素对 VLBW 婴儿其他临床结局的影响。